Masters Athletes With Abnormal Cardiovascular Findings: A Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESC and the American College of Cardiology.

However, emerging evidence suggests that Masters athletes may have a higher prevalenceof cardiovascular abnormalities, such as atrial arrhythmias, coronary atherosclerosis, aortic dilatation, and myocardial fibrosis, compared to their less active peers.

然而，新兴的证据表明，与那些活动量较少的同龄人相比，老年运动员可能有更高的心血管异常的患病率，如房性心律失常、冠状动脉粥样硬化、主动脉扩张和心肌纤维化。

The clinical management of Masters athletes may be challenging as available guidelines for such conditions are generally based on data derived from symptomatic sedentary patients, limiting their applicability to highly trained individuals.

Masters运动员的临床管理可能具有挑战性，因为目前针对这些状况的指南通常基于来自有症状的久坐患者的资料，这限制了它们对高度训练个体的适用性。

Other unique challenges in the clinical assessment of Masters athletes include differences in symptomatic presentations compared to sedentary individuals, potential resistance to the initiation of pharmacologic treatment, and the increasing availability of consumer wearable health data that may provide relevant information on their cardiovascular health status.

在Masters运动员的临床评估中，还有其他独特的挑战，包括与久坐个体相比症状表现的差异，对启动药物治疗的潜在抵触，以及消费者可穿戴健康数据的日益普及，这些数据可能提供了有关他们心血管健康状况的相关信息。

The purpose of this joint EAPC/ESC and ACC Clinical Consensus Statement is to provide an in-depth update on the current state of knowledge on abnormal cardiovascular findings in Masters athletes.

这份欧洲姑息治疗学会(EAPC)/欧洲心脏病学会(ESC)和美国心脏病学会(ACC)的临床共识声明的目的是提供关于老年运动员异常心血管发现当前知识状态的深入更新。

We present an expert-based approach on the diagnostic assessment, management, and prognosis of (i) atrial fibrillation, (ii) bradyarrhythmias, (iii) ventricular arrhythmias, (iv) coronary atherosclerosis, (v) aortic dilatation, (vi) myocardial fibrosis, and (vii) exercise-induced arrhythmogenic cardiomyopathy.

我们提出了一个基于专家的方法，关于(i)心房颤动、(ii)心动过缓、(iii)室性心律失常、(iv)冠状动脉粥样硬化、(v)主动脉扩张、(vi)心肌纤维化以及(vii)运动诱发的心律失常性心肌病的诊断评估、管理以及预后。

Clinical challenges, areas of ongoing controversy, and uncertainty and the potential underlying mechanisms are discussed.

讨论了临床挑战、持续争议的领域、不确定性和潜在的潜在机制。

We also present future perspectives and research directives to further refine current best practice strategies.

我们还提出了未来展望和研究方向，以进一步完善当前的最佳实践策略。

This includes the need for clinical outcome studies, dedicated randomized controlled trials in athletes, and international registries with diverse populations and longitudinal follow-up to evaluate the natural history of cardiac abnormalities and facilitate development of evidence-based approaches in the clinical management of Masters athletes with cardiovascular abnormalities.

这包括需要进行临床结果研究、针对运动员的专门随机对照试验，以及具有多样化人群和长期随访的国际登记，以评估心脏异常的自然病史，并促进在临床管理中发展基于证据的方法，以处理具有心血管异常的高级别运动员。